Cargando…

Prognostic effect of different PD-L1 expression patterns in squamous cell carcinoma and adenocarcinoma of the cervix

Programmed death-ligand 1 (PD-L1) is expressed in various immune cells and tumor cells, and is able to bind to PD-1 on T lymphocytes, thereby inhibiting their function. At present, the PD-1/PD-L1 axis is a major immunotherapeutic target for checkpoint inhibition in various cancer types, but informat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heeren, A Marijne, Punt, Simone, Bleeker, Maaike CG, Gaarenstroom, Katja N, van der Velden, Jacobus, Kenter, Gemma G, de Gruijl, Tanja D, Jordanova, Ekaterina S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931542/ https://www.ncbi.nlm.nih.gov/pubmed/27056074 http://dx.doi.org/10.1038/modpathol.2016.64

Ejemplares similares

Classical and non-classical HLA class I aberrations in primary cervical squamous- and adenocarcinomas and paired lymph node metastases
por: Ferns, Debbie M., et al.
Publicado: (2016)

Nodal metastasis in cervical cancer occurs in clearly delineated fields of immune suppression in the pelvic lymph catchment area
por: Heeren, A. Marijne, et al.
Publicado: (2015)

PD-L1 and PD-L2 Expression in Cervical Cancer: Regulation and Biomarker Potential
por: Rotman, Jossie, et al.
Publicado: (2020)

Evidence for a coordinate role of CD14+ antigen-presenting cells and regulatory T cells in conditioning the microenvironment of metastatic lymph nodes from patients with cervical cancer
por: Heeren, Marijne, et al.
Publicado: (2014)

Immune landscape in vulvar cancer-draining lymph nodes indicates distinct immune escape mechanisms in support of metastatic spread and growth
por: Heeren, Anne Marijne, et al.
Publicado: (2021)

Unlocking the therapeutic potential of primary tumor-draining lymph nodes
por: Rotman, Jossie, et al.
Publicado: (2019)

Immunotherapeutic Approaches for the Treatment of HPV-Associated (Pre-)Cancer of the Cervix, Vulva and Penis
por: Rafael, Tynisha S., et al.
Publicado: (2022)

Indoleamine 2,3-Dioxygenase Expression Pattern in the Tumor Microenvironment Predicts Clinical Outcome in Early Stage Cervical Cancer
por: Heeren, A. Marijne, et al.
Publicado: (2018)

High-efficiency lysis of cervical cancer by allogeneic NK cells derived from umbilical cord progenitors is independent of HLA status
por: Veluchamy, John P., et al.
Publicado: (2016)

Neoadjuvant cisplatin and paclitaxel modulate tumor-infiltrating T cells in patients with cervical cancer
por: Heeren, A. Marijne, et al.
Publicado: (2019)

Efficacy of PD-1 blockade in cervical cancer is related to a CD8(+)FoxP3(+)CD25(+) T-cell subset with operational effector functions despite high immune checkpoint levels
por: Heeren, A. M., et al.
Publicado: (2019)

The Prognostic Value of Immune Factors in the Tumor Microenvironment of Penile Squamous Cell Carcinoma
por: Ottenhof, Sarah Rosanne, et al.
Publicado: (2018)

The risk of lymph node metastasis in the new FIGO 2018 stage IA cervical cancer with >7 mm diameter
por: Nicolai, Laure, et al.
Publicado: (2023)

Galectin-1, -3 and -9 Expression and Clinical Significance in Squamous Cervical Cancer
por: Punt, Simone, et al.
Publicado: (2015)

Pretreatment tumour-antigen Ta-4 in serum of patients with squamous cell carcinoma of the uterine cervix.
por: Kenter, G., et al.
Publicado: (1987)

‘DURVIT’: a phase-I trial of single low-dose durvalumab (Medi4736) IntraTumourally injected in cervical cancer: safety, toxicity and effect on the primary tumour- and lymph node microenvironment
por: Rotman, J., et al.
Publicado: (2018)

MGL Ligand Expression Is Correlated to Lower Survival and Distant Metastasis in Cervical Squamous Cell and Adenosquamous Carcinoma
por: Sahasrabudhe, Neha M., et al.
Publicado: (2019)

Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma
por: Mehta, Akash M., et al.
Publicado: (2007)

Squamous and adenocarcinoma of the uterine cervix: a comparison using routine data.
por: Silcocks, P. B., et al.
Publicado: (1987)

FoxP3(+) and IL-17(+) cells are correlated with improved prognosis in cervical adenocarcinoma
por: Punt, Simone, et al.
Publicado: (2015)

Cancer immunophenotyping by seven‐colour multispectral imaging without tyramide signal amplification
por: Ijsselsteijn, Marieke E, et al.
Publicado: (2018)

Comparison of risk factors for squamous cell and adenocarcinomas of the cervix: a meta-analysis
por: Berrington de González, A, et al.
Publicado: (2004)

PD-L1 Expression in Squamous-cell Carcinoma and Adenocarcinoma of the Lung
por: Janzic, Urska, et al.
Publicado: (2017)

Primary endometrioid adenocarcinoma of the cervix with widespread squamous metaplasia – a potential diagnostic pitfall
por: Hirschowitz, Lynn, et al.
Publicado: (2007)

Small cell neuroendocrine carcinoma with adenocarcinoma and high grade squamous intraepithelial neoplasia of the cervix
por: Gurubalan, Guralarasan, et al.
Publicado: (2023)

Role of FAM19A4/miR124-2 methylation analysis in predicting regression or non-regression of CIN2/3 lesions: a protocol of an observational longitudinal cohort study
por: Kremer, Wieke W, et al.
Publicado: (2019)

Conservative treatment of coexisting microinvasive squamous and adenocarcinoma of the cervix: report of two cases and literature review
por: Sopracordevole, Francesco, et al.
Publicado: (2016)

The impact of examined lymph node count on survival in squamous cell carcinoma and adenocarcinoma of the uterine cervix
por: Zhou, Juan, et al.
Publicado: (2017)

Ovarian preservation in adenocarcinoma of the uterine cervix
por: Zhou, Jiansong, et al.
Publicado: (2017)

Bone Involvement by Adenocarcinoma of the Uterine Cervix: A Rare Entity
por: Crisci, Vincenzina, et al.
Publicado: (2015)

A Review of the Effects of Cervical Cancer Standard Treatment on Immune Parameters in Peripheral Blood, Tumor Draining Lymph Nodes, and Local Tumor Microenvironment
por: van Luijk, Iske F., et al.
Publicado: (2022)

Human papillomavirus 16 infection in adenocarcinoma of the cervix
por: Chew, G K, et al.
Publicado: (2005)

Early Stage Adenocarcinoma of Cervix with Ovarian Micrometastasis
por: Singh, Pratibha, et al.
Publicado: (2017)

Expression of CHOP in Squamous Tumor of the Uterine Cervix
por: Chu, Hyun Hee, et al.
Publicado: (2012)

Micro-environmental cross-talk in an organotypic human melanoma-in-skin model directs M2-like monocyte differentiation via IL-10
por: Michielon, Elisabetta, et al.
Publicado: (2020)

Correlations between immune response and vascularization qRT-PCR gene expression clusters in squamous cervical cancer
por: Punt, Simone, et al.
Publicado: (2015)

Jagged-1 induced molecular alterations in HPV associated invasive squamous cell and adenocarcinoma of the human uterine cervix
por: Tripathi, Richa, et al.
Publicado: (2018)

Comparison of treatment outcomes between squamous cell carcinoma and adenocarcinoma of cervix after definitive radiotherapy or concurrent chemoradiotherapy
por: Hu, Ke, et al.
Publicado: (2018)

Impact of opportunistic screening on squamous cell and adenocarcinoma of the cervix in Germany: A population-based case-control study
por: Tanaka, Luana F., et al.
Publicado: (2021)

Sentinel lymph node procedure in patients with recurrent vulvar squamous cell carcinoma: a proposed protocol for a multicentre observational study
por: van Doorn, Helena C., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2eote7m1sobafqihqqflc4frn9